Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Supercritical Fluid Technologies (SFT) is a specialized provider of high-pressure laboratory and process-scale equipment for supercritical fluid extraction (SFE) and chromatography (SFC). The company serves the pharmaceutical, biotechnology, and natural products industries by providing environmentally friendly separation and purification solutions using supercritical carbon dioxide. Their product portfolio includes versatile systems like the SFT-120 and SFT-250, which are widely utilized for method development and small-scale production. Beyond hardware, SFT offers contract research services and analytical support to help clients optimize extraction yields and purity profiles for complex molecules. The company is headquartered in Newark, Delaware, and maintains a global distribution network to support its international client base.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Supercritical Fluid Technologies.